Search

everythinglearnresearchcommunity

for

Search:↓

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Creating evidence-based guidelines for gender incongruence is difficult due to the personalized nature of transgender medicine.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Hormone therapy for trans individuals is effective and generally safe in the short term.

India is seeing more cases of gender incongruence and changes in how it's understood and managed legally and medically.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Gender identity can be more diverse than just male or female.

The US Military supports transgender health care, but many needed skin procedures aren't covered by insurance.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Transgender individuals face insurance barriers to gender-affirming surgery, needing policy reforms for better access.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.